Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Ipatasertib Combinations for Breast Cancer
Recruiting2 awardsPhase 1 & 2
Duarte, California
This trial is testing a new drug, ipatasertib, to see if it can help treat triple negative breast cancer. Ipatasertib works by blocking some of the enzymes needed for cell growth. The trial will test different combinations of ipatasertib with other drugs to see which works best.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.